A pair of biotechs prepares to hit Nasdaq, as total 2021 IPO raise quickly approaches $3B

After a busy week last week when 10 biotechs went public, the industry continues to see a steady stream of companies making their debuts.

With Adagene pricing earlier this week and two more biotechs joining them late Thursday into early Friday, there have now been 16 companies to IPO so far in 2021. The total combined raise is rapidly rising and approaching $3 billion already — biotechs have pulled in roughly $2.86 billion thus far.